Fingerprint
Dive into the research topics of 'Randomized, open-label phase II study evaluating the efficacy and safety of talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone in patients with advanced, unresectable melanoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically